Journal article

Rationale, Opportunities, and Reality of Biosimilar Medications

John R Zalcberg

New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2018


Funding Acknowledgements

Dr. Zalcberg reports receiving lecture fees and travel support from Pfizer and fees for serving on advisory boards from Pfizer and Amgen. No other potential conflict of interest relevant to this letter was reported.